MS Views and News Be empowered with MS views and news. CLICK HERE - - to SUBSCRIBE for The MS BEACON e-Newsletter


MS Views and News uses state-of-the-art technology to provide resources to the MS Community. Visit our MS learning channel on YouTube, to gain knowledge from hundreds of MS educational videos presented by MS Experts from across the USA. Click: www.youtube.com/msviewsandnews

Within this blog you can find MS resources by viewing all showing below pertaining to thousands of MS articles, resources, event timing. Additionally, please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for those affected by Multiple Sclerosis. * From the comfort of your home, you can join us for our VIRTUAL MS events. To learn more of these virtual events please subscribe here.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Thursday, December 3, 2015

Multiple Sclerosis Drug Does Not Cause Cancer

Researchers from the Queen Mary University of London are calling on healthcare professionals to reinitiate development of a multiple sclerosis (MS) drug until more evidence about its risk of cancer is published. 

Their piece is published in the journal Neurology: Neuroimmunology & Neuroinflammation. The authors wrote that their new evidence contradicts the belief that the drug causes cancer.   

Cladribine is already licensed for leukemia patients – but it can also be used to treat MS as shown in previous studies in the United Kingdom, the authors explained. In one trial, the editorialists outlined, the drug reduced MS relapses by more than 50 percent. In the same study, nearly 50 percent of people who received treatment with the drug did not demonstrate any signs of disease activity for the subsequent two years.   

However, based on previous data, the drug was refused market authorization, they wrote, because of the suspicion that it may cause cancer.


 - See more at: http://www.hcplive.com/medical-news/multiple-sclerosis-drug-does-not-cause-cancer-#sthash.02PFyzxU.dpuf


~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
MS Views and News helps to provide information for all affected by MS
Keep up to date with the news and information we provide 
by signing up by clicking here
.===================================

No comments: